NONALCOHOLIC FATTY LIVER
Clinical trials for NONALCOHOLIC FATTY LIVER explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a hormone pill shrink fatty liver? small study explores ibutamoren
Disease control CompletedThis pilot study tested whether ibutamoren, a drug that boosts growth hormone, can reduce fat buildup in the liver of people with nonalcoholic fatty liver disease (NAFLD). Twelve generally healthy adults with NAFLD took the drug for 6 months. Researchers measured changes in liver…
Matched conditions: NONALCOHOLIC FATTY LIVER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
Massive study tracks fatty liver disease to guide future treatments
Knowledge-focused CompletedThis study followed over 7,300 people with nonalcoholic fatty liver disease (NAFLD) or its more severe form, NASH, in regular medical clinics. The goal was to learn how the disease progresses over time and how doctors currently treat it, since there are no approved medications. T…
Matched conditions: NONALCOHOLIC FATTY LIVER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC